- Home
- ZNTL vs PESI Comparison
ZNTL vs PESI Comparison
Compare ZNTL & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | PESI |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | 305 |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 243.9M |
| IPO Year | 2020 | 1992 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | PESI |
|---|---|---|
| Price | $1.86 | $13.44 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 775.6K | 92.3K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $26,865,000.00 | ★ $60,661,000.00 |
| Revenue This Year | N/A | $9.91 |
| Revenue Next Year | N/A | $62.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $6.25 |
| 52 Week High | $3.32 | $16.50 |
Technical Indicators
Market Signals| Indicator | ZNTL | PESI |
|---|---|---|
| Relative Strength Index (RSI) | 78.09 | 54.54 |
| Support Level | $1.31 | $12.09 |
| Resistance Level | $1.46 | $13.04 |
| Average True Range (ATR) | 0.10 | 0.55 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 72.92 | 76.34 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.